What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Activities Defensa de Tesi 'Asthma due to exposure to allergens and other environmental pollutants: inflammatory and immunologic response' Doctorand: David Soler Segovia, grup de Recerca Pneumologia. Vall d'Hebron Institut de Recerca (VHIR)Directors: Dra. María Jesús Cruz Carmona i Dr. Xavier Muñoz GallTutora: Dra. María Jesús Cruz Carmona News The 2024 revision of the McDonald criteria will allow an even earlier diagnosis of multiple sclerosis The Lancet Neurology publishes the new criteria, the result of a global expert consensus led by Dr Xavier Montalban. News A new oral drug for obesity shows positive results in an international study with Vall d’Hebron participation The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors. News VHIR has successfully renewed the HR Excellence in Research Award granted by the European Commission First awarded in 2015 and renewed in 2021, this 2025 renewal reaffirms VHIR’s commitment to fostering a transparent, ethical, inclusive, and high-quality research environment. Activities Vall d'Hebron Talks by VHIR 'Sepsis Code Update: Where We Are and Where We Are Heading' Speaker: Dr. Marcio Borges Sa, Coordinator of the Multidisciplinary Unit of Sèpsia of the Son Llatzer Hospital of Palma de Mallorca.In this session, we will address the impact of implementing the Sepsis Code in different healthcare settings, highlighting the need for individualized a News VHIR takes part in the GIMM Festival 2025 in Lisbon with activities on ageing and longevity The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation. News We host the first Vall d’Hebron - Mayo Clinic day on innovation in nephrology The event, organized jointly by Vall d’Hebron and the Mayo Clinic, offered specialized talks reviewing the latest developments and challenges in the field of nephrology. Activities 1rst Mayo Clinic - Vall d'Hebron - NEPHROLOGY UPDATE Oriol Bestard Matamoros Hospital Universitari Vall d´Hebron. BarcelonaMaría José Soler Romeo Hospital Universitari Vall d´Hebron. BarcelonaSandra Herrmann, 1rst Mayo Clinic - Vall d´Hebron September 5-6, 2025 NEPHROLOGY UPDATE Directors: Mayo Clinic. Rochester, USAFernando Fe News EN Genetic risk for psychiatric disorders is linked to emotional and behavioural problems in children without a diagnosis EN Genetic susceptibility to developing ADHD shows the strongest association with mental health problems during childhood and adolescence, compared to genetic risk for other psychiatric conditions. News Vall d’Hebron develops a questionnaire to measure critical thinking in physiotherapists Critical thinking enables these professionals to analyse each clinical situation more reflectively and rigorously in order to improve patient care. News The Technological Boost Fund awards a total of €43,500 to three projects in its first 2025 edition FIT is an initiative aimed at funding projects developed at VHIR with high impact and market transfer potential. News The TRUSTroke project, coordinated by Vall d'Hebron, launches a clinical study to develop an AI-based solution for the follow-up of stroke patients A retrospective study has been carried out with data from 11,000 patients to train artificial intelligence algorithms and adapt the Nora mobile application to different patient profiles. News Formation Bio Licenses First-in-Class Anti-CD226 Autoimmune Program from IMIDomics Transaction expands Formation Bio's immunology pipeline with Phase 1 ready drug candidate. News Strong presence of VHIR at the European Alliance of Associations for Rheumatology Congress 15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations. News Fundaluce supports research into a new therapeutic strategy for retinitis pigmentosa at Vall d’Hebron Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss. News Vall d'Hebron shows the benefits on microbiota of a diet rich in vegetables, fruit, legumes and whole grains The study, involving a thousand participants from different regions of Spain, shows that diet influences the diversity and composition of the microbiota and, therefore, health. News RBDCOV final event highlights legacy and lessons learned The project, in which Vall d’Hebron participates, studied the Bimervax® vaccine in immunocompromised individuals and paediatric patients. News FDA grants orphan drug designation to a gene therapy for ALS developed in collaboration with VHIR The treatment, licensed to Klotho Neurosciences, is based on a technology developed at the Universitat Autònoma de Barcelona (UAB) with the participation of VHIR. Activities Vall d'Hebron Talks by VHIR 'A multidimensional diagnostic approach for chronic obstructive pulmonary disease' Speaker: Dr. Raúl San José Estépar, Co-Director, Applied Chest Imaging Laboratory-Lead Investigator, Brigham and Women’s Hospital-Associate Professor of Radiology, Harvard Medical SchoolIndividuals at risk for chronic obstructive pulmonary disease (COPD) but without spirometric airflo News Presentation of the VHIR Annual Report 2024 El informe incluye los datos y los resultados científicos e institucionales más destacados del centro durante el año. Pagination First page « Previous page ‹ … Page 2 Page 3 Current page 4 Page 5 Page 6 … Next page › Last page »
